← Evidence map

ArticlePharmaceutics2023

An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties.

Cesare Di Nitto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36839699